You just read:

Novartis Gains FDA Approval for Amturnide™, a Triple-Combination Pill to Treat High Blood Pressure in Patients Uncontrolled on Two Medications

News provided by

Novartis Pharmaceuticals Corporation

Dec 22, 2010, 04:05 EST